Tumors with high heterogeneity are associated with reduced immune cell infiltration and impaired immunomodulatory gene expression, which leads to lower anti-tumor immune responses, including declines in CD8+ T cells, M1-like macrophages, and T follicular helper cells, while promoting tumorigenic M2-like macrophages [30]. This evidence concerns the gene CD8A and neoplasm.